Omics Profiling of Weight Loss With Bariatric Surgery (Bariatric)

Omics Profiling of the Response to Food and Variability of Weight Loss With Bariatric Surgery

Understanding how foods and nutrients are digested, absorbed and metabolized when weight is stable and during weight loss induced by bariatric surgery procedure using the technologies of genomics, transcriptomics, proteomics, metabolomics and fluxomics ("omics") will enable generation of new hypotheses that could explain the inter-individual differences in weight loss and could lead to optimization and individualization of therapies designed to lose weight.

Study Overview

• Status: Unknown
• Conditions: Obesity; Surgery
• Intervention / Treatment: Other: Stable isotope infusion

Detailed Description

The overarching hypothesis is that there are baseline, pre- and post-surgery combinations of 'omics' signatures in response to food and nutrients that explain the weight loss response of obese subjects to the pre-operative very low calorie (VLC) diet and to bariatric surgery.

In order to address the general hypothesis the following specific aims will be addressed:

Specific Aim 1: To test the hypothesis that there is a combination of 'omics' parameters in response to a defined meal that discriminate between morbidly obese subjects and normal weight subjects.

Specific Aim 2: To test the hypothesis that variation in % weight loss to the VLC diet prior to bariatric surgery is related to baseline genomic markers, gene expression profile, proteomic and metabolomic signatures as well as baseline metabolic and substrates fluxomics response to a defined meal.

Specific Aim 2: To test the hypothesis that variation in % weight loss 3 months after bariatric surgery is related to baseline genomic markers, gene expression profile, proteomic and metabolomic signatures as well as baseline metabolic and substrates fluxomics response to a defined meal.

Specific Aim 3: To test whether there are "omics" characteristics post-surgery that track with variability in weight loss at 3 months.

The benefit of these experiments will be the knowledge gained from understanding the variation in % weight loss to the medically required VLC diet prior to bariatric surgery, and to bariatric surgery, in relation to baseline genomic markers, gene expression profile, proteomic and metabolomic signatures as well as baseline metabolic and substrates fluxomics response to a defined meal in obese and healthy adults.

• Study Type: Interventional
• Enrollment (Anticipated): 50
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Texas
    • College Station, Texas, United States, 77843
      • Texas A&M University-CTRAL

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion criteria obese subjects:

• Diagnosed with morbid obesity (defined as BMI > 40 kg/m2 or BMI > 35 kg/m2 with at least one serious comorbidity (1991 NIH compendium guidelines))
• Scheduled for bariatric surgery
• Age 18 years and older
• Ability to lie in supine or elevated position for 9 hours
• Willingness and ability to comply with the protocol

Inclusion criteria healthy subjects:

• Healthy male or female according to the investigator's or appointed staff's judgment
• Ability to walk, sit down and stand up independently
• Age 18 years or older
• Ability to lie in supine or elevated position for 9 hours
• Willingness and ability to comply with the protocol

Exclusion Criteria

• Any condition that may interfere with the definition 'healthy subject' according to the investigator's judgment (for healthy control group only)
• Presence of fever within the last 3 days
• Untreated metabolic diseases including hepatic or renal disorder unrelated to the primary disease
• Presence of acute illness or metabolically unstable chronic illness unrelated to the primary disease
• (Possible) pregnancy
• Any other condition according to the PI or nurse that would interfere with the study or safety of the patient
• Failure to give informed consent
• Use of protein or amino acid containing nutritional supplements within 3 days of first test day

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Healthy matched controls; screening visit: body weight and composition by DXA, height, and vital signs will be assessed. Subjects may sign a medical release form to obtain medical and psychological information about them that will help determine study eligibility or can be used for later coding. study day: muscle mass and function tests, resting energy expenditure, stable isotope infusions with blood draws, and questionnaires regarding quality of life, mood and depression, diet.	Other: Stable isotope infusion; such as glycerol, D2O, tyrosine, phenylalanine, glucose, arginine, and citrulline
Experimental: Obese subjects; screening visit: body weight and composition by DXA, height, and vital signs will be assessed. Subjects may sign a medical release form to obtain medical and psychological information about them that will help determine study eligibility or can be used for later coding. 3 study days (one baseline, one pre-surgery, one post-surgery): muscle mass and function tests, resting energy expenditure, stable isotope infusions with blood draws, and questionnaires regarding quality of life, mood and depression, diet.	Other: Stable isotope infusion; such as glycerol, D2O, tyrosine, phenylalanine, glucose, arginine, and citrulline

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Net whole-body protein synthesis	Change in whole-body protein synthesis rate after intake of meal	0, 2, 5, 10, 15, 20, 30, 40, 50, 60, 90, 120, 150, 180, 210, 225, 240, 260, 280, 300, 320, 340, 360 ± 5 min

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Gut function	Digestion of the stable tracers of amino acid	In postabsorptive and prandial state every 20 minutes up to 6 hours before each sip feeding on study day
Group differences in state of mood as measured by the Hospital Anxiety and Depression Scale (HADS),	a fourteen item self-assessment scale. Seven of the items related to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression.	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Executive Function-Adolescent/Adult Sensory Profile (ASP):	a standardized self-questionnaire that generates an individualized profile of sensory processing across four quadrants: low registration, sensation seeking, sensory sensitivity, and sensation avoiding.	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Group differences in quality of life as measured by Short Form (36) Health Survey (SF36)	self administered questionnaire that measures each of the following eight health concepts: Physical Functioning (PF); Role-Physical (RP); Bodily Pain (BP); General Health (GH); Vitality (VT); Social Functioning (SF); Role-Emotional (RE); Mental Health (MH) as well as a reported Health Transition item (HT).	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Group differences in activity as measured by Physical Activity Scale for the Elderly (PASE)	questionnaire is intended for use in an elderly population and focuses on 3 types of activities: leisure time activities, household activities and work-related activities.	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Group differences in attention and executive functions as measured by Stroop Color-Word Test (SCWT),	a word page with words printed in black ink, a color page with blocks printed in color, and a color-word page where the color and the word do not match. The examinee reads the words or names the ink colors as quickly as possible within a time limit. Measures selective attention and inhibitory control. The total time in seconds was reported for each trial.	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Group differences in state of mood as measured by the Profile of Mood State (POMS)	A psychological distress scale to measure mood disturbance in 6 domains - fatigue-inertia, vigor-activity, tension-anxiety, depression-dejection, anger-hostility, and confusion-bewilderment. Healthy populations take 3 to 7 minutes to complete, and others may take up a bit longer.	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Group differences in learning and memory as measured by Controlled Oral Word Association Test (COWAT),	Controlled Oral Word Association Test (COWAT): The examinee is required to say as many words as they can think of in one minute that begin with a given letter of the alphabet. The task contains three trials. Measures phonetic verbal fluency. The raw score (total and mean words recorded across the three trials) was reported.	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Group differences in learning and memory as measured by Auditory Verbal Learning Test (AVLT)	Auditory Verbal Learning Test (AVLT): a verbal episodic memory test that evaluates a wide diversity of functions: short-term auditory-verbal memory, rate of learning, retention and recognition of information.	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Group differences in attention and executive functions as measured by PASAT	a measure of cognitive function that assesses auditory information processing speed and flexibility, as well as calculation ability.	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Group differences in attention and executive functions as measured by Trail Making Test (TMT),	In Part A, the examinee is instructed to connect a set of 25 circles with numbers as quickly as possible while maintaining accuracy. In Part B, the examinee is instructed to connect a set of 25 circles, alternating between numbers and letters, as quickly as possible while maintaining accuracy. Measures attentional resources and is a measure of the frontal lobe "executive" functions of visual search, set-switching and mental flexibility. The total time in seconds was reported for each measure.	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Group differences in overall cognitive abilities as measured by Montreal Cognitive Assessment (MoCA)	assesses several cognitive domains and is used for the screening of mild cognitive impairment. Total scores range from 0-30 with lower scores indicating decreased functioning.	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Group differences in attention and executive functions as measured by Brief-A	a standardized self-report that captures views of an adult's executive functions or self-regulation in his or her everyday environment.	Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3 (obese only)
Skeletal muscle strength	handgrip and kin-com 1-leg test	on study day 1 and the change from day 2 and day 3 (obese only)
diet recall	The subject is asked to recall in detail all the food and drink consumed during the 24 hours prior to the test day.	on study day 1 and the change from day 2 and day 3 (obese only)
Respiratory muscle strength	Maximum inhalation and exhalation pressure	on study day 1 and the change from day 2 and day 3 (obese only)
Body Composition	Body composition as measured by Dual-Energy X-ray Absorptiometry on study day 1 and the change from day 2 and day 3 (obese only)	on study day 1 and the change from day 2 and day 3 (obese only)

Collaborators and Investigators

• Sponsor: Texas A&M University

Publications and helpful links

General Publications

• Wierzchowska-McNew RA, Engelen MPKJ, Thaden JJ, Ten Have GAM, Deutz NEP. Obesity- and sex-related metabolism of arginine and nitric oxide in adults. Am J Clin Nutr. 2022 Dec 19;116(6):1610-1620. doi: 10.1093/ajcn/nqac277.

Study record dates

Study Major Dates

• Study Start: October 1, 2015
• Primary Completion (Anticipated): October 1, 2020
• Study Completion (Anticipated): October 1, 2021

Study Registration Dates

• First Submitted: February 1, 2016
• First Submitted That Met QC Criteria: April 27, 2016
• First Posted (Estimate): May 2, 2016

Study Record Updates

• Last Update Posted (Actual): May 29, 2020
• Last Update Submitted That Met QC Criteria: May 27, 2020
• Last Verified: May 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Body Weight; Body Weight Changes; Weight Loss
• Other Study ID Numbers: 2014-0651

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO